Literature DB >> 7163815

Studies with ifosfamide in patients with malignant lymphoma.

V Rodriguez, F Cabanillas, G P Bodey, E J Freireich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7163815

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

Authors:  C Manegold; P Worst; J Bickel; H Schmid; P Drings; M Kaufmann
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Hypersensitivity reactions from antineoplastic agents.

Authors:  R B Weiss; J R Baker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Toxicity of high-dose ifosfamide in children.

Authors:  S M Davies; A D Pearson; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Cis-dichlorodiammineplatinum (cis-platinum) and etoposide (VP-16) in malignant lymphoma--an effective salvage regimen.

Authors:  I R Judson; E Wiltshaw
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.